Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Ted Bosworth

    News

    Emapalumab produces major responses in macrophage activation syndrome

    Author:
    Ted Bosworth
    Publish date: July 9, 2019

    MADRID – In systemic juvenile idiopathic arthritis complicated by MAS, new therapy produces rapid complete responses.

    • Read More

    News

    Obesity might be targetable driver of psoriatic arthritis progression

    Author:
    Ted Bosworth
    Publish date: June 26, 2019

    MADRID – Two studies show how obesity correlates with greater psoriatic arthritis disease activity and disability and how substantial weight loss...

    • Read More

    News

    Leflunomide added to glucocorticoids reduces relapse in IgG4-related disease

    Author:
    Ted Bosworth
    Publish date: June 26, 2019

    MADRID – Adding leflunomide to standard glucocorticoids doubles the median remission in IgG4-related disease....

    • Read More

    News

    Despite advances, imaging of axSpA remains an adjunctive tool

    Author:
    Ted Bosworth
    Publish date: June 26, 2019

    MADRID – Supported by data, experts agree that diagnosis and assessment of axSpA is aided but not dependent on imaging.

    • Read More

    News

    Experts agree on routine lung disease screening in systemic sclerosis

    Author:
    Ted Bosworth
    Publish date: June 19, 2019

    MADRID – Expert management recommendations for interstitial lung disease in systemic sclerosis advise matching frequency of screening to risk.

    • Read More

    News

    Checkpoint inhibitor–induced rheumatic complications have unique features

    Author:
    Ted Bosworth
    Publish date: June 19, 2019

    MADRID – The phenotypic musculoskeletal complications of checkpoint inhibitors do not resemble other joint pathology.

    • Read More

    News

    Booster vaccines found largely safe in children on immunosuppressive drugs

    Author:
    Ted Bosworth
    Publish date: June 16, 2019

    MADRID – Live vaccine boosters appear safe in children with rheumatic diseases on...

    • Read More

    Video

    Ultra low-dose rituximab retains promise in rheumatoid arthritis

    Author:
    Ted Bosworth
    Publish date: June 15, 2019

    MADRID – Despite failing to meet study criteria, ultra low-dose rituximab strategy...

    • Read More

    Video

    Retention rates comparable for biosimilars, original drug in spondyloarthritis

    Author:
    Ted Bosworth
    Publish date: June 15, 2019

    MADRID – One-year treatment data drawn from registries in five Scandinavian countries.

    • Read More

    Video

    Video program engages patients in treat-to-target concept

    Author:
    Ted Bosworth
    Publish date: June 15, 2019

    MADRID – Previous lack of awareness of this concept might be responsible for lack of adherence to therapy.

    • Read More

    News

    EULAR issues guidelines on managing rheumatic complications of cancer immunotherapies

    Author:
    Ted Bosworth
    Publish date: June 14, 2019

    The new guidelines are tailored for rheumatologists, and address diagnosis and treatment.

    • Read More

    Video

    Patients with CAPS still improving on long-term canakinumab

    Author:
    Ted Bosworth
    Publish date: June 14, 2019

    MADRID – The RELIANCE study is longitudinally monitoring patients with cryopyrin-associated periodic syndrome...

    • Read More

    News

    Weight loss in knee OA patients sustained with liraglutide over 1 year

    Author:
    Ted Bosworth
    Publish date: June 14, 2019

    MADRID – After an intensive weight-loss program, liraglutide not only sustained but further improved weight loss.

    • Read More

    Video

    Patient selection important for osteoarthritis structural and symptom endpoints

    Author:
    Ted Bosworth
    Publish date: June 13, 2019

    MADRID – Dr. Philip G. Conaghan discusses the difficulties in reconciling structural and symptomatic endpoints in osteoarthritis trials.

    • Read More

    Video

    Major increase in hidradenitis suppurativa cases anticipated

    Author:
    Ted Bosworth
    Publish date: May 29, 2019

    CHICAGO – “For decades ... we’ve really not understood how prevalent it is.”

    • Read More

    Pages

    • « first
    • …
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery